secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0001193125-26-062599
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA grants PMA approval for Allurion gastric balloon system for obesity
-----------------------------------------------------------------------

- Allurion Smart Capsule approved for adults 22-65 with BMI 30-40 kg/m² after unsuccessful weight loss attempt.
- Balloon swallowed in 15-min office visit, no surgery/endoscopy/anesthesia; stays ~4 months, then passes naturally.
- AUDACITY pivotal trial data supported approval; over 200,000 patients treated outside US with 14% total body weight loss.
- Opens access to ~80 million US adults with obesity; alternative to GLP-1s and bariatric surgery.
- Company cited 65% GLP-1 discontinuation rate within first year and rapid weight regain as unmet need.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/0001193125-26-062599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/alur-20260223.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-062599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer